Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Biot Korea is a South Korean private medical robotics and healthcare technology company focused on minimally invasive therapeutic delivery and automated diagnostic sample collection. The company is best known for its Magnectio platform, which uses magnetically actuated micro-scaffolds or microrobots to deliver therapeutic materials, including stem cell-based payloads, to targeted sites, and for its RAPIDS platform for automated respiratory specimen collection and molecular diagnostics. It also markets HyuFIL, a surgical support solution used to wash out saline residue and temporarily replace lost synovial fluid during arthroscopic procedures. Biot Korea appears to operate at the intersection of medical devices, microrobotics, regenerative medicine enablement, and diagnostic automation rather than as a traditional drug-development biotech. The company is headquartered in Gwangju, South Korea and has pursued international commercialization and partnership activity, including overseas market development efforts.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Biot Korea.